P61.5 Transient neonatal neutropenia

Name of the Condition

• Transient Neonatal Neutropenia
  
  • ICD-10-CM Code: P61.5

Summary

Transient neonatal neutropenia is a temporary reduction in the number of neutrophils (a type of white blood cell) in newborns. Neutrophils play a key role in fighting infections, so this condition may increase susceptibility to bacterial infections during the neonatal period. The neutropenia typically resolves within weeks as the infant’s immune system matures.

Causes

The condition often arises from factors affecting neutrophil production or survival in the newborn. Common causes include maternal hypertension, placental insufficiency, or infections during pregnancy. It may also occur due to delayed maturation of the infant’s bone marrow or transient suppression of neutrophil production shortly after birth.

Risk Factors

• Premature birth
• Maternal hypertension or preeclampsia
• Intrauterine growth restriction (IUGR)
• Maternal infections during pregnancy
• Perinatal asphyxia or hypoxia
• Sepsis or other infections in the newborn

Symptoms

• Fever or hypothermia
• Poor feeding or lethargy
• Respiratory distress
• Skin infections or abscesses
• Unexplained irritability or jitteriness
• Signs of sepsis (e.g., tachycardia, hypotension)

Diagnosis

Diagnosis is confirmed through a complete blood count (CBC) showing a low absolute neutrophil count. Additional tests, such as blood cultures or inflammatory markers, may be performed to rule out infections or other underlying conditions. Clinical evaluation of the infant’s overall health and risk factors is also essential.

Treatment Options

• Close monitoring for signs of infection, especially in high-risk infants.
• Antibiotic therapy if infection is suspected or confirmed.
• Supportive care, including temperature regulation and nutritional support.
• In severe cases, granulocyte colony-stimulating factor (G-CSF) may be considered to stimulate neutrophil production.

Prognosis and Follow-Up

Most cases of transient neonatal neutropenia resolve spontaneously within 2–4 weeks as the infant’s neutrophil count normalizes. Prognosis is generally good with appropriate monitoring and prompt treatment of any infections. Follow-up blood counts may be recommended to ensure resolution and assess immune function.

Complications

• Increased risk of bacterial infections, such as sepsis or pneumonia.
• Potential for prolonged hospitalization if infections develop.
• Rarely, progression to more severe neutropenia or other hematological disorders.

Lifestyle & Prevention

• Ensure adequate prenatal care to manage maternal conditions (e.g., hypertension) that may contribute to the risk.
• Prompt evaluation and treatment of infections in the newborn.
• Supportive care measures, such as maintaining a sterile environment and monitoring vital signs, to reduce infection risk.

When to Seek Professional Help

Seek immediate medical attention if the infant shows signs of infection (e.g., fever, poor feeding, respiratory distress) or if neutropenia is diagnosed and symptoms worsen. Early intervention is critical to prevent complications.

Tips for Medical Coders

• Code P61.5 is specific to transient neonatal neutropenia and should be used when the condition is documented in the newborn’s record.
• Ensure documentation supports the transient nature of the neutropenia (e.g., resolution within weeks) and excludes other causes of neutropenia (e.g., genetic disorders or sepsis).
• Verify that the diagnosis aligns with clinical findings, such as low neutrophil counts and associated symptoms, to support accurate coding.